Princeton, NJ -- (SBWIRE) -- 06/01/2018 -- Global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.

Explore more info about this report @ https://www.researchcosmos.com/reports/iucd-market-analysis-global-industry-outlook-and-forecast-2017-to-2024/1731619905

The global intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Based on geography, the global intra-uterine contraceptive devices market is segmented into 5 geographical regions such as:
North America
South America
Europe
APAC
MEA
Rest Of the World

Request for Sample @ https://www.researchcosmos.com/request/1731619905

Global intra-uterine contraceptive devices (IUCD) market competition by top players including:
1) Bayer AG
2) DKT International
3) Egemen International
4) Melbea AG
5) Ocon Medical Ltd.
6) Pregna International Limited
7) Medical Engineering Corporation SA

Ask For Customization @ https://www.researchcosmos.com/customization/1731619905

About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We're associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

Contact Us:
Kevin Stewart
Sales Manager
Research Cosmos
www.researchcosmos.com
kevin@researchcosmos.com
Phone: +1 888 709 8757